» Articles » PMID: 29194734

In Vivo Characterization of Brain Ultrashort-T Components

Overview
Journal Magn Reson Med
Publisher Wiley
Specialty Radiology
Date 2017 Dec 2
PMID 29194734
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Recent nuclear magnetic resonance and MRI studies have measured a fast-relaxing signal component with T2∗<1 ms in white matter and myelin extracts. In ex vivo studies, evidence suggests that a large fraction of this component directly arises from bound protons in the myelin phospholipid membranes. Based on these results, this ultrashort-T component in nervous tissue is a new potential imaging biomarker of myelination, which plays a critical role in neuronal signal conduction across the brain and loss or degradation of myelin is a key feature of many neurological disorders. The goal of this work was to characterize the relaxation times and frequency shifts of ultrashort-T components in the human brain.

Methods: This required development of an ultrashort echo time relaxometry acquisition strategy and fitting procedure for robust measurements in the presence of ultrashort T2∗ relaxation times and large frequency shifts.

Results: We measured an ultrashort-T component in healthy volunteers with a median T2∗ between 0.5-0.7 ms at 3T and 0.2-0.3 ms at 7T as well as an approximately -3 ppm frequency shift from water.

Conclusion: To our knowledge, this is the first time a chemical shift of the ultrashort-T brain component has been measured in vivo. This chemical shift, at around 1.7 ppm, is similar to the primary resonance of most lipids, indicating that much of the ultrashort-T component observed in vivo arises from bound protons in the myelin phospholipid membranes. Magn Reson Med 80:726-735, 2018. © 2017 International Society for Magnetic Resonance in Medicine.

Citing Articles

Water phase transition and signal nulling in 3D dual-echo adiabatic inversion-recovery UTE (IR-UTE) imaging of myelin.

Athertya J, Shin S, Malhi B, Lo J, Sedaghat S, Jang H Magn Reson Med. 2024; 92(6):2464-2472.

PMID: 39119819 PMC: 11436297. DOI: 10.1002/mrm.30243.


Quantification of the in vivo brain ultrashort-T* component in healthy volunteers.

Deveshwar N, Yao J, Han M, Dwork N, Shen X, Ljungberg E Magn Reson Med. 2024; 91(6):2417-2430.

PMID: 38291598 PMC: 11076235. DOI: 10.1002/mrm.30013.


Clinical evaluation of white matter lesions on 3D inversion recovery ultrashort echo time MRI in multiple sclerosis.

Sedaghat S, Jang H, Ma Y, Afsahi A, Reichardt B, Corey-Bloom J Quant Imaging Med Surg. 2023; 13(7):4171-4180.

PMID: 37456321 PMC: 10347363. DOI: 10.21037/qims-22-1317.


The signal intensity variation of multiple sclerosis (MS) lesions on magnetic resonance imaging (MRI) as a potential biomarker for patients' disability: A feasibility study.

Sedaghat S, Jang H, Athertya J, Groezinger M, Corey-Bloom J, Du J Front Neurosci. 2023; 17:1145251.

PMID: 36992852 PMC: 10040653. DOI: 10.3389/fnins.2023.1145251.


Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status.

van der Weijden C, Biondetti E, Gutmann I, Dijkstra H, McKerchar R, Faria D Brain. 2022; 146(4):1243-1266.

PMID: 36408715 PMC: 10115240. DOI: 10.1093/brain/awac436.


References
1.
Englund E . Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord. 1998; 9 Suppl 1:6-12. DOI: 10.1159/000051183. View

2.
Larson P, Gurney P, Nayak K, Gold G, Pauly J, Nishimura D . Designing long-T2 suppression pulses for ultrashort echo time imaging. Magn Reson Med. 2006; 56(1):94-103. PMC: 2942755. DOI: 10.1002/mrm.20926. View

3.
Larson P, Han M, Krug R, Jakary A, Nelson S, Vigneron D . Ultrashort echo time and zero echo time MRI at 7T. MAGMA. 2015; 29(3):359-70. PMC: 4892974. DOI: 10.1007/s10334-015-0509-0. View

4.
Bergin C, Pauly J, Macovski A . Lung parenchyma: projection reconstruction MR imaging. Radiology. 1991; 179(3):777-81. DOI: 10.1148/radiology.179.3.2027991. View

5.
Uecker M, Lai P, Murphy M, Virtue P, Elad M, Pauly J . ESPIRiT--an eigenvalue approach to autocalibrating parallel MRI: where SENSE meets GRAPPA. Magn Reson Med. 2013; 71(3):990-1001. PMC: 4142121. DOI: 10.1002/mrm.24751. View